Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study

Affiliation auteurs!!!! Error affiliation !!!!
TitreInfliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study
Type de publicationJournal Article
Year of Publication2020
AuteursMertz P, Kleinmann J-F, Lambert M, Puechal X, Bonnin A, Boulon C, Diot E, Hachulla E, Harid N, Harle J-R, Helder G, Kahn J-E, Kone-Paut I, Lavigne C, Magy-Bertrand N, Maillard H, Martin T, Maurier F, Poindron V, Schleinitz N, Sibilia J, Arnaud L
JournalAUTOIMMUNITY REVIEWS
Volume19
Pagination102634
Date PublishedOCT
Type of ArticleLetter
ISSN1568-9972
Mots-clésBiotherapies, Glucocorticoid-sparing, infliximab, Takayasuarteritis, vasculitis
DOI10.1016/j.autrev.2020.102634